ABL Diagnostics Expands Verification of DeepChek® on Additional MGI NGS Platforms to Enhance Microbiology Genotyping
Now Offering Native Library Preparation Kits and Workflow Automation for MGI Instruments WOIPPY, FRANCE, May 28, 2025 /EINPresswire.com/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in molecular diagnostics, …